Journal of the European Academy of Dermatology and Venereology 2020-Feb
Pemetrexed-induced edema of the eyelids and scalp in a patient with metastatic lung cancer.
Μόνο εγγεγραμμένοι χρήστες μπορούν να μεταφράσουν άρθρα
Σύνδεση εγγραφή
Ο σύνδεσμος αποθηκεύεται στο πρόχειρο
Λέξεις-κλειδιά
Αφηρημένη
Pemetrexed is an anti-metabolite that targets multiple enzymes in the folate pathway and it is indicated in the treatment of locally advanced or metastatic non-small cell lung carcinoma and malignant pleural mesothelioma. On September, 2008, the U.S. FDA (Food and Drug Administration) approved its use in combination with cisplatin for the initial treatment of patients with stage IIB/IV nonsquamous non-small cell lung carcinoma.